LCI 1413 (Hydrochlorothiazide 25 mg)

Pill imprint LCI 1413 has been identified as Hydrochlorothiazide 25 mg.

Hydrochlorothiazide is used in the treatment of high blood pressure; edema; diabetes insipidus; nephrocalcinosis; osteoporosis and belongs to the drug class thiazide diuretics. There is no proven risk in humans during pregnancy. Hydrochlorothiazide 25 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for LCI 1413

Hydrochlorothiazide 25 mg LCI 1413
Hydrochlorothiazide 25 mg LCI 1413
Hydrochlorothiazide
Imprint:
LCI
1413
Strength:
25 mg
Color:
Orange
Size:
6.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Thiazide diuretics
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Lannett Company, Inc.
National Drug Code (NDC):
00527-1413
Inactive Ingredients:
lactose monohydrate
microcrystalline cellulose
FD&C Yellow No. 6
D&C Yellow No. 10
silicon dioxide colloidal
sodium starch glycolate type A potato
magnesium stearate
aluminum oxide

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)